Differential activation of the death receptor pathway in human target cells induced by cytotoxic T lymphocytes showing different kinetics of killing

Haematologica. 2007 Dec;92(12):1671-8. doi: 10.3324/haematol.11308.

Abstract

Background and objectives: Cytotoxic T lymphocytes (CTL) may use two effector mechanisms to kill their target cells: perforin (PFN) and granzyme B (GrB)-dependent granule-mediated cell death and death receptor-mediated cell death. Controversy exists whether, in addition to PFN/GrB-mediated apoptosis, death receptor-induced apoptosis contributes to the elimination of human tumor cells by CTL.

Design and methods: Since the two CTL-mediated effector mechanisms differ in time required to eliminate target cells, lysis of target cells was analyzed using CTL clones with slow and rapid kinetics of killing derived from a patient with chronic myeloid leukemia. To determine the involvement of the death receptor pathway, a retroviral construct encoding the antiapoptotic gene FLICE inhibitory protein (FLIP) was introduced into these target cells.

Results: A CTL clone capable of killing 50% of the target cells within 2 hours of incubation primarily acted by release of PFN and GrB. In contrast, two CTL clones showing slower target cell killing kinetics partially used the death receptor pathway (approximately 30% inhibition by FLIP).

Interpretation and conclusions: We demonstrated that the death receptor pathway contributes to T-cell-mediated cell death if not all target cells are destroyed by release of PFN and GrB.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / genetics
  • Apoptosis / immunology*
  • CASP8 and FADD-Like Apoptosis Regulating Protein / genetics
  • CASP8 and FADD-Like Apoptosis Regulating Protein / immunology
  • Caspase 8 / immunology
  • Caspase Inhibitors
  • Cell Death / genetics
  • Cell Death / immunology
  • Granzymes / immunology*
  • Humans
  • Immunity, Cellular / genetics
  • Immunity, Cellular / immunology
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / genetics
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / immunology*
  • Perforin / immunology*
  • Receptors, Tumor Necrosis Factor / immunology
  • Retroviridae
  • T-Lymphocytes / immunology*
  • Time Factors
  • Transduction, Genetic
  • Tumor Cells, Cultured

Substances

  • CASP8 and FADD-Like Apoptosis Regulating Protein
  • Caspase Inhibitors
  • Receptors, Tumor Necrosis Factor
  • Perforin
  • Granzymes
  • CASP8 protein, human
  • Caspase 8